Generation of replication competent viruses for therapeutic use

Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S091410, C536S023100, C424S214100, C424S224100, C424S229100, C424S232100, C424S233100

Reexamination Certificate

active

07550296

ABSTRACT:
The present invention relates to the generation of replication-competent viruses having therapeutic utility. The replication-competent viruses of the invention can express proteins useful in the treatment of disease.

REFERENCES:
patent: 5843772 (1998-12-01), Devine et al.
patent: 6291214 (2001-09-01), Richards et al.
patent: 6420524 (2002-07-01), Craig
patent: 2002/0042137 (2002-04-01), Richards et al.
Arafat et al., Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv, 2002, Gene Therapy, vol. 9, pp. 256-262.
Roshon et al., Gene trap mutagenesis of hnRNP A2/B1: a cryptic 3′ splice site in the neomycin resistance gene allows continued expression of the disrupted cellular gene, 2003, BMC Genomics, vol. 4, No. 2, pp. 1-11.
Stellwagan et al., “Gain-of-Function Mutations in TnsC, an ATP-Dependent Transposition Protein That Activates the Bacterial Transposon Tn7.”Genetics. (1997), 145: 573-585.
Luckow et al., “Efficient Generation of Infectious Recombinant Baculoviruses By Site-Specific Transposon-Mediated Insertion of Foreign Genes into a Baculovirus Genome Propagated inEscherichia coli.” J. Virol. (1993), 67: 4566-4579.
Richards et al., “The Admid System: Generation of Recombinant Adenoviruses by Tn7-Mediated Transposition inE.coli.” BioTechniquesvol. 29, No. 1: pp. 146-154 (2000).
Biery et al., “A simple In Vitro Tn7-Based Transposition System With Low Target Site Selectivity for Genome and Gene Analysis.”Nucleic Acids Res. (2000) 28:1067-1077.
Hermiston et al., “Armed Therapeutic Viruses: Strategies and Challenges to Arming Oncolytic Viruses With Therapeutic Genes.”Cancer Gene Therapy, (2002) vol. 9, No. 12, pp. 1022-1035.
Lee et al., “Replicating Adenoviral Vector-mediated Transfer of a Heat-inducible Double Suicide Gene for gene Therapy.”Cancer Gene Therapy, (2001) vol. 8, No. 6, pp. 397-404.
Kretschmer et al., “Development of a Transposon-Based Approach for Identifying Novel Transgene Insertion Site Within the Replicating Adenoviruses.”Molecular Therapy, (2005) vol. 12, No. 1, pp. 118-127.
Jin et al., “Identification of Novel Insertion Sites in the Ad5 Genome That Utilize the Ad Splicing Machinery for Therapeutic Gene Expression.”Molecular Therapy, (2005) vol. 12, No. 6, pp. 1052-1063.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Generation of replication competent viruses for therapeutic use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Generation of replication competent viruses for therapeutic use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Generation of replication competent viruses for therapeutic use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4137102

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.